AHA urges Congress to include key priorities to support hospitals and caregivers in must-pass legislation to fund the government beyond Feb. 18.
Letters
Throughout the year, the AHA comments on a vast number of proposed and interim final rules put forth by the federal regulatory agencies. In addition, AHA communicates with federal legislators to convey the hospital field's position on potential legislative changes that would impact patients and patient care. Below are the most recent letters from the AHA to these bodies.
Latest
AHA letter to Reps. Tom Cole, R-Okla., Markwayne Mullin, R-Okla., and Dina Titus, D-Nev., and Sens. Jim Inhofe, R-Okla., and Jacky Rosen, D-Nev, expressing support for the Medical Student Education Authorization Act.
January 11, 2022
Michael Chernew, Ph.D.
Chairman
Medicare Payment Advisory Commission
425 I Street, N.W., Suite 701Washington, DC 20001
Dear Dr. Chernew:
January 11, 2022
President Joseph R. Biden
The White House
1600 Pennsylvania Avenue, N.W. Washington, DC 20500
Dear President Biden:
January 11, 2022
The Honorable Xavier Becerra
Secretary
U.S. Department of Health and Human Services
200 Independence Avenue, S.W.
Washington, D.C. 20201
Letter to CMS with comments on the agency’s interim final rule for a mandatory COVID-19 vaccination policy for hospitals and other Medicare/Medicaid participants.
The SUNSET rule set expiration dates for the vast majority of HHS regulations unless certain conditions are met. Specifically, the department must conduct a review of most of its regulations at certain intervals and then determine whether they should retain, modify, or eliminate the regulation.
Responding to a recent request for input from the field, the AHA yesterday urged the Center for Medicare and Medicaid Innovation to balance the risk and reward in its alternative payment models “in a way that reflects the significant investments required to launch and maintain APM participation.”
AHA today strongly urged the departments of Health and Human Services, Labor and Treasury and Office of Personnel Management to restore the independence of the independent dispute resolution process in the No Surprises Act Part 2 regulations.
The AHA today submitted comments on the Food and Drug Administration’s revised draft guidance on hospital and health system compounding under Section 503A of the Federal Food, Drug, and Cosmetic Act.